{"title":"剂量密集的紫杉醇联合卡铂是否应该成为治疗亚理想减积患者或接受新辅助化疗患者的新标准?","authors":"Marilyn Huang, Robert L. Coleman","doi":"10.1016/j.cogc.2013.12.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100274,"journal":{"name":"Clinical Ovarian and Other Gynecologic Cancer","volume":"5 2","pages":"Pages 51-52"},"PeriodicalIF":0.0000,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cogc.2013.12.002","citationCount":"0","resultStr":"{\"title\":\"Should Dose-dense Paclitaxel in Combination With Carboplatin Be the New Standard for Treatment for Suboptimally Debulked Patients or Patients Treated With Neoadjuvant Chemotherapy?\",\"authors\":\"Marilyn Huang, Robert L. Coleman\",\"doi\":\"10.1016/j.cogc.2013.12.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100274,\"journal\":{\"name\":\"Clinical Ovarian and Other Gynecologic Cancer\",\"volume\":\"5 2\",\"pages\":\"Pages 51-52\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.cogc.2013.12.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Ovarian and Other Gynecologic Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212955313000069\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Ovarian and Other Gynecologic Cancer","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212955313000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Should Dose-dense Paclitaxel in Combination With Carboplatin Be the New Standard for Treatment for Suboptimally Debulked Patients or Patients Treated With Neoadjuvant Chemotherapy?